Navigation Links
USHEALTH Group Launches Marketing Program for Two Health Insurance Plans Targeting Latino Residents in Florida
Date:9/12/2008

FORT WORTH, Texas, Sept. 12 /PRNewswire/ -- Benjamin M. Cutler, Chairman and Chief Executive Officer of USHEALTH Group, Inc. (USHEALTH), a leading national health insurer providing affordable coverage to small business owners and the self-employed, announced today the launch of two health plans culturally adapted for the Hispanic market in Florida. The two plans offer a wide selection of healthcare coverages and options for cost-conscious consumers. The two plans and the corresponding marketing materials were specifically designed with the Florida Hispanic community in mind.

According to recent U.S. Census population statistics in 2006, Hispanics represent more than 20 percent of the population in Florida, and this growth rate is expanding rapidly. Unfortunately, this large population is also likely to be without healthcare coverage. Currently, the National Council of La Raza estimates that 33 percent of Latinos are without health insurance, and experts think this trend will continue to rise as the Hispanic population increases.

"Many traditional healthcare plans do not address the specific needs of the Hispanic market," said Cutler. "A family-oriented culture, Hispanics wants good, affordable healthcare coverage. In evaluating the needs of this thriving population, USHEALTH identified a variety of health care plans with value-priced coverage that are ideally suited for the Hispanic market. To build awareness of these products, USHEALTH has created a targeted marketing campaign to help inform Hispanic consumers about the range of health insurance plans that are especially tailored for them."

"We recognize that a huge segment of the Hispanic market in Florida is comprised of small business owners and self-employed businessmen and women who have a long term need for affordable health coverage," Cutler noted. "As such, they need a health plan that assures them of affordable coverage, not just for a few months, but for several years. Our fixe
'/>"/>

SOURCE USHEALTH Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. USHEALTH Group Announces Appointment of Executive Vice President
2. Lucas Group Reports Hiring Trend in High-Tech Medical Device
3. Savannah Mayor Otis Johnson Honored as Healthy Hero by The AMERIGROUP Foundation
4. To Reduce Mercury Pollution, Dentists need a mandatory requirement, According to US House Oversight Report; Mercury Group Concurs
5. Faircount Media Group Choose "Call-Shadow" for IP Call Recording After Extensive Market Review
6. Heritage Victor Valley Medical Group to Donate Computers to Victorville Senior Citizen Club
7. CtW Investment Group Believes Longs RE Undervalued - Calls for Greater Disclosure
8. Conde Nast Media Group Announces Performance of Just Stand Up to be Fed Live from the Stage at FASHION ROCKS to ABC, CBS and NBCs Simultaneous Broadcast of Stand Up To Cancer Nationwide Fund-Raising Event On September 5th
9. Sharon Callahan Joins Diversified Agency Services Unit of Omnicom Group
10. San Francisco Bay Area Cell Analysis Company Forges Partnership With Hudson Control Group as First Step in Automation Initiative to Support Drug Discovery Research
11. iCan Benefit Group, LLC Announces: Major Medical Division Now Offers Avalon Healthcare Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...gist explains prevalence of winter diaper rash and...sh season , COLLEGEVILLE, Pa., Dec. 2 /PRNewsw...per-clad babies, the winter months can mean cute l...nd not-so-cute and oh-so-painful little red bottom... until sunscreen season comes around again. , ...
(Date:12/2/2008)...alif., Dec. 2 The natio...oday to President-elect Obama urging him to fulfil...le and available by allowing any American to join ...a that a proposal pushed by health insurance compa...h insurance policies "amounts only to a government...
(Date:12/2/2008)...dy finds natural, less expensive treatments are ef... , PRINCETON, N.J., Dec. 2 Wi...oliday season is, for most, anticipated with excit... who suffer from Irritable Bowel Syndrome (IBS), t... embarrassing and debilitating gastrointestinal at...
(Date:12/2/2008)...nts treated with radiation prior to surgery for ad...r recurrence and better overall survival rates, ac...rt examined a treatment called neoadjuvant therapy...he spread of cancer, before surgery to remove the ...y and/or radiation. , Neoadjuvant therapy shoul...
Breaking Medicine News(10 mins):Health News:Photos: Heads Up, Parents: Get to the Bottom of Winter Diaper Rash 2Health News:Photos: Heads Up, Parents: Get to the Bottom of Winter Diaper Rash 3Health News:Photos: Heads Up, Parents: Get to the Bottom of Winter Diaper Rash 4Health News:Consumer Watchdog to Obama: Open Medicare to All Americans 2Health News:Consumer Watchdog to Obama: Open Medicare to All Americans 3Health News:Holiday Season Brings New Hope to Millions Who Suffer from Common Chronic Health Disorder 2
...00 personnel of the Central Reserve Police Force (...en found to be addicted to drugs and alcohol// , a...the survey to find out the number of men who have ...ound 426 alcohol and drug addicts," said a senior ...
...esearchers have discovered that fatty acid ethyl e...iably portray the extent of fetal alcohol exposure...e if an infant has been exposed to alcohol during ...trictly associated with alcohol use," said Enrique...
...e sector YES Bank has signed an MoU with a leading... up a 75-100 million dollar health care fund cater...hs. // The Netherlands-based equity house will ru...ank would be the advisor. This would be its first ...
...ing to a new study, men with prostate cancer are m...ional changes, which prevents them //from trustin...isconceptions on the disease management options an...f others with prostate cancer to their own conditi...
Other Medicine News:Health News:Misconception on Treatment Options among Prostate Cancer Patients 2
(Date:12/2/2008)...PRNewswire/ -- Horizon Therapeutics, Inc., a,priv...ced that two pivotal,Phase 3 trials evaluating it...,met all primary endpoints. HZT-501, a novel, pro...g ibuprofen and famotidine, demonstrated a,statis...non-steroidal,anti-inflammatory drug (NSAID)-indu...
(Date:12/1/2008)...AGO, Dec. 2 A study has... new technique for imaging the breast, is not affe...l status, two factors that limit the effectiveness...er. Results will be presented today at the annual ...ca (RSNA). , , "The ability of PEM to dete...
(Date:12/1/2008)...ewswire/ -- S*BIO Pte Ltd today announced the init...potent and orally-active JAK2 inhibitor, in leadin...hronic idiopathic myelofibrosis (CIMF). , , ... tolerability of SB1518 in patients with CIMF and ... 1 part of the study will assess the safety profil...
(Date:12/1/2008)...he Prox1 gene is a two-way switch that, if turned ...ogrammed so that they lose their identity and beco...MPHIS, Tenn., Dec. 1 S... have discovered that a certain differentiated cel...requires the constant expression of a gene called ...
Breaking Medicine Technology:Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Cell Therapeutics Inc 28CTI 29 Prices 241 27 million 28euros 856 000 29 Offering of Common Stock through Societe Generale 2589 1Cell Therapeutics Inc 28CTI 29 Prices 241 27 million 28euros 856 000 29 Offering of Common Stock through Societe Generale 2589 2BioSpecifics Technologies Corp Announces Sale of Stock in Private Placement Offering 2587 1Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer 9536 1Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer 9536 2Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer 9536 3Rwandas Gishwati Forest selected as site for historic conservation project 1899 1Rwandas Gishwati Forest selected as site for historic conservation project 1899 2Rwandas Gishwati Forest selected as site for historic conservation project 1899 3
...RE)--Apr 19, 2007 - Amgen,(NASDAQ: AMGN) today ann...d, double-blind, placebo-controlled, multicenter P...00 previously untreated,patients with extensive-st...um-containing chemotherapy. The study demonstrated...f death (overall,survival Aranesp compared to plac...
...Apr 18, 2007 - Critical,Therapeutics, Inc. (Nasdaq...rch demonstrating a role in chronic inflammatory,a...otein (HMGB1), a,pro-inflammatory mediator and nuc... May 2007 issue of Nature Immunology. The,publicat...es that,can stimulate immune cells to produce pote...
Other Medicine Technology:Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 2Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 3Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 4Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 5Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 6Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 7Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 2Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 3Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 4Critical Therapeutics Announces the Publication of New Preclincial,HMGB1 Data in Nature Immunology 5
...clear, all-silicone Foley catheters eliminate pati... designs. As an inert, toxin-free elastomer, silic... catheter. Unlike silicone-coated latex Foleys, Ro...leach chemicals or water-soluble proteins that can...
Used for stone manipulation and removal in the urinary tract. Enhanced wire strength permits the basket to expand the ureter more readily than standard flat-wire designs. The Unidex handle facilitate
Used for stone manipulation and removal in the urinary tract. Enhanced wire strength permits greater radial dilation in the ureter. The Unidex handle facilitates easy, ergonomic one-handed operation.
Used to establish and maintain nephrostomy drainage following pyeloplasty. The open ureteral segment promotes patency and allows the stent to adjust as edema subsides. Supplied sterile in peel-open p
Medicine Products: